Next-generation sequencing (NGS) technology can provide a broad view of the human genome, helping us discover and apply relevant genomic information to human health. Ultimately, identifying and understanding changes in the genome may lead to more accurate diagnosis, prognosis, and therapeutic selection.
We are working with a growing number of partners to develop new clinical assays that provide needed solutions to some of our greatest health challenges.
Illumina is a leading provider of accurate, reliable NGS solutions. Now clinical laboratories can take advantage of powerful NGS technology with the MiSeqDx System.
At the heart of the system is the MiSeqDx instrument, stringently validated for design and performance. Along with the MiSeqDx instrument, Illumina offers the TruSeq Custom Amplicon Kit Dx for clinical labs to develop their own in vitro diagnostic (IVD) assays and expand their offerings to meet a wide variety of customer needs.
Interested in developing your own diagnostic test with the MiSeqDx System?